SATB1 and neoplasm: In an initial study on breast cancer, SATB1 was demonstrated to act as a genetic master switch towards a more aggressive tumour behaviour, and moreover, high immunohistochemical expression of SATB1 in tumours fom a large cohort of breast cancer patients was an independent marker of poor prognosis [8].